pharmaphorum

SEPTEMBER 11, 2020

Prior to the $63 billion takeover by AbbVie, Allergan’s biggest product was botulinum toxin product Botox, best known as a wrinkle and migraine treatment, and that headed a sizeable medical aesthetics portfolio at the company which also included dermal filler products like Juvederm.

Botox 117

Botox Filler Production Marketing 117

Roots Analysis

JANUARY 29, 2024

The treatments / products provided by medical aesthetics companies used for facial aesthetic procedures have been mentioned below: Botulinum toxin: It is a toxin produced by a bacterium, Clostridium botulinum , commonly referred to as Botox. General anesthesia is necessary for the procedure, and injections and fillers may also be used.

Filler 40

Filler Cosmetics Botox Marketing 40

Roots Analysis

JANUARY 3, 2024

Afterwards, in 2003, the FDA approved Hyaluronic Acid Fillers (HA dermal fillers), bringing the much-anticipated innovation to all types of face and non-face augmentation products. Moreover, at present, women dominate the medical aesthetics industry with over 90% market share.

Filler 40

Filler Cosmetics Production Dermatology 40